About Arranta Bio
Arranta Bio is a company based in Watertown (United States) founded in 2019 was acquired by Recipharm in February 2022.. Arranta Bio has raised $82 million across 1 funding round from investors including Thermo Fisher Scientific, Recipharm and Ampersand Capital Partners. Arranta Bio has completed 1 acquisition, including Captozyme. Arranta Bio operates in a competitive market with competitors including KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
- Headquarter Watertown, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$82 M (USD)
in 1 rounds
-
Latest Funding Round
$82 M (USD), Series C
Oct 30, 2019
-
Investors
Thermo Fisher Scientific
& 2 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
Recipharm
(Feb 27, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Arranta Bio
Arranta Bio has successfully raised a total of $82M through 1 strategic funding round. The most recent funding activity was a Series C round of $82 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series C — $82.0M
-
First Round
First Round
(30 Oct 2019)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2019 | Amount | Series C - Arranta Bio | Valuation | Ampersand Capital , Thermo Fisher Scientific |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Arranta Bio
Arranta Bio has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Thermo Fisher Scientific, Recipharm and Ampersand Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Founded Year | Domain | Location | |
|
Electron microscopy services and microanalysis instruments are provided.
|
Founded Year | Domain | Location | |
|
Pharmaceutical development and manufacturing services are offered contractually.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Arranta Bio
Arranta Bio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Captozyme. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Enzyme-based products for kidney stones and hyperoxaluria are developed.
|
2009 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Arranta Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Arranta Bio Comparisons
Competitors of Arranta Bio
Arranta Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| domain | founded_year | HQ Location |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| domain | founded_year | HQ Location |
Integrated biologics development and manufacturing are provided as a CDMO.
|
|
| domain | founded_year | HQ Location |
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
|
|
| domain | founded_year | HQ Location |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| domain | founded_year | HQ Location |
Precision fermentation services for biopharma and food are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Arranta Bio
Frequently Asked Questions about Arranta Bio
When was Arranta Bio founded?
Arranta Bio was founded in 2019.
Where is Arranta Bio located?
Arranta Bio is headquartered in Watertown, United States.
Is Arranta Bio a funded company?
Arranta Bio is a funded company, having raised a total of $82M across 1 funding round to date. The company's 1st funding round was a Series C of $82M, raised on Oct 30, 2019.
What does Arranta Bio do?
Arrantabio is a contract development and manufacturing organization focusing on the development of therapeutics for the treatment of human microbiome-related diseases. The company develops live biotherapeutic products through bacterial fermentation, isolation, drying, and encapsulation technologies for treating diseases associated with the human microbiome. It offers companies development and cGMP services such as cell banking, frozen blend, drug substance, primary packaging, analytical services and many more.
Who are the top competitors of Arranta Bio?
Arranta Bio's top competitors include KBI Biopharma, Aldevron and Ovagen.
How many acquisitions has Arranta Bio made?
Arranta Bio has made 1 acquisition, including Captozyme.
Who are Arranta Bio's investors?
Arranta Bio has 3 investors. Key investors include Thermo Fisher Scientific, Recipharm, and Ampersand Capital Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.